ATE11224T1 - Wundheilende zusammensetzungen. - Google Patents

Wundheilende zusammensetzungen.

Info

Publication number
ATE11224T1
ATE11224T1 AT81102848T AT81102848T ATE11224T1 AT E11224 T1 ATE11224 T1 AT E11224T1 AT 81102848 T AT81102848 T AT 81102848T AT 81102848 T AT81102848 T AT 81102848T AT E11224 T1 ATE11224 T1 AT E11224T1
Authority
AT
Austria
Prior art keywords
wound healing
substances
compositions
healing compositions
active
Prior art date
Application number
AT81102848T
Other languages
English (en)
Inventor
Rolf Dr. Schaefer
Original Assignee
Rolf Dr. Schaefer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolf Dr. Schaefer filed Critical Rolf Dr. Schaefer
Application granted granted Critical
Publication of ATE11224T1 publication Critical patent/ATE11224T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
AT81102848T 1980-04-17 1981-04-14 Wundheilende zusammensetzungen. ATE11224T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH297280 1980-04-17
EP81102848A EP0038511B1 (de) 1980-04-17 1981-04-14 Wundheilende Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE11224T1 true ATE11224T1 (de) 1985-02-15

Family

ID=4245769

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81102848T ATE11224T1 (de) 1980-04-17 1981-04-14 Wundheilende zusammensetzungen.

Country Status (5)

Country Link
EP (1) EP0038511B1 (de)
JP (1) JPS5738716A (de)
AT (1) ATE11224T1 (de)
CA (1) CA1168980A (de)
DE (1) DE3168248D1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA833446B (en) 1982-05-28 1984-02-29 Solco Basel Ag Process for the preparation of cell-and tissue-regenerating substances
CH658785A5 (de) * 1984-06-15 1986-12-15 Pentapharm Ag Haemostyptisch wirksames hautpflegemittel.
US4699788A (en) * 1984-08-20 1987-10-13 Trustees Of Boston University Angiogenic factor methods of extraction and method for producing angiogenesis
US4767746A (en) * 1985-12-04 1988-08-30 Trustees Of Boston University Method for enhancement of healing of epithelial wounds in mammals
US4778787A (en) * 1985-12-20 1988-10-18 Trustees Of Boston University Method for treatment of angina and myocardial infarctions with omental lipids
US4990333A (en) * 1985-12-20 1991-02-05 Angio Medical Corporation Method for healing bone damage
NL8720257A (nl) * 1986-06-13 1988-05-02 Japan Immuno Res Lab Wondbehandelingspreparaat en kosmeticum.
CH671516A5 (de) * 1986-09-16 1989-09-15 Amcis Ag
EP0274547A1 (de) * 1986-12-18 1988-07-20 Trustees Of Boston University Verfahren zur Steigerung der epithelialen Wundheilung bei Säugetieren
AT392003B (de) * 1988-01-13 1991-01-10 Broschek G Chem Prod Gebro Verfahren zur herstellung eines insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes aus saeugetierblut durch papainhydrolyse und ein einen solchen wirkstoff enthaltendes praeparat
WO1999018920A1 (en) * 1997-10-16 1999-04-22 Deguang Zhu A new powerful cosmetic or pharmaceutical composition
CN110652493A (zh) * 2019-10-31 2020-01-07 福建蓝昊肽生物科技发展有限公司 一种增加生物活性肽乳膏稳定性的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2710294A (en) * 1953-11-02 1955-06-07 Olin Mathieson Blood fractionation
US3973001A (en) * 1954-04-27 1976-08-03 Solco Basel Ag Tissue cell stimulating blood extracts
US2912359A (en) * 1955-05-04 1959-11-10 Developments Inc Wound healing agent obtained from blood and method of preparation
US3128268A (en) * 1961-10-18 1964-04-07 Canada Packers Ltd Recovery of complex lipid material and preparation of corresponding fatty acid alkylesters
FR1345565A (fr) * 1962-01-19 1963-12-13 Rolland Lab A Procédé pour l'obtention d'extraits totaux plus généralement orginaires de tissus viants
DE1910715A1 (de) * 1968-03-04 1969-10-09 Stanley Drug Products Inc Antimikrobielle Faktoren und deren Verwendung
AT295036B (de) * 1968-11-29 1971-12-27 Leikola Erkki E Verfahren zur Herstellung von neuen Produkten tierischen Ursprungs
BE790707A (fr) * 1971-10-28 1973-02-15 Dso Pharmachim Remede contre les maladies du systeme arteriel peripherique, contusions, engelures, plaies atones et sclerodermie en
US3953290A (en) * 1973-04-30 1976-04-27 Ab Kabi Polypeptides as vitro active cell growth enhancing factors and methods of use
FR2257268A1 (en) * 1973-11-08 1975-08-08 Souron Yves Collection and storage of bone marrow - under non oxidising conditions to prevent deterioration
US4054557A (en) * 1974-05-15 1977-10-18 Ab Kabi Growth promoting polypeptides and preparation method
IT1046051B (it) * 1975-08-13 1980-06-30 Fidia Spa Nuova applicazione terapeutica dei gangliosidi e procedimento per la loro estrazione
US4139611A (en) * 1975-12-24 1979-02-13 Helmut Mittenzweig Organic peptide containing substance recovered from blood having insulin-like activity

Also Published As

Publication number Publication date
CA1168980A (en) 1984-06-12
DE3168248D1 (en) 1985-02-28
JPH0318603B2 (de) 1991-03-13
EP0038511B1 (de) 1985-01-16
JPS5738716A (en) 1982-03-03
EP0038511A3 (en) 1982-08-18
EP0038511A2 (de) 1981-10-28

Similar Documents

Publication Publication Date Title
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
DE69033040D1 (de) Verfahren zur Herstellung von biologisch aktivem Protein (z.B. TGF)
SE8000469L (sv) Vevnadsbindmedel och forfarande for dess framstellning samt bindmedlets anvendning
DE68928956D1 (de) Verfahren zur Herstellung von optisch aktivem 1,3-Butanediol
DE69011878D1 (de) Von Hydrogel angetriebene Verabreichungsvorrichtung.
ATE79763T1 (de) Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
LV10178A (lv) Fiziologiski saderigu glabajot stabilu cilveka olbaltumvielu preparatu iegusanas panemiens
DE69033487D1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
EP0439629A4 (en) Device for irradiating laser beams
ATE70191T1 (de) Knochenzement zur kontrollierten abgabe von wirkstoffen.
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
ATE7697T1 (de) Substituierte pyrazinyl-1,2,4-oxadiazol-5-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE11224T1 (de) Wundheilende zusammensetzungen.
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
DE2961609D1 (en) Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation
ATE111883T1 (de) Neue antiulcus-substanz.
FI801228A (fi) 6-substituerade 11-alkylen-morfantridiner foerfaranden foer deras framstaellning och terapeutiska medel innehaollande dessa
ES2073391T3 (es) Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre.
DE69129747D1 (de) In lösung bringen von proteinen in aktiver form
ATE64300T1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
DK325289D0 (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
DE59304087D1 (de) Placentaextrakt und Verfahren zu seiner Herstellung
BE868956A (fr) Composition destinee au traitement de l'hypocalcemie, et de l'hypophosphatemie chez les animaux

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee